Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1996
12/25/1996CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones
12/25/1996CN1138575A 4-aminobenzoylguanidine derivatives
12/24/1996US5587505 Triterpene derivatives and endothelin-receptor antagonists containing the same
12/24/1996US5587380 Certain 2,4-diamino-5-(2,3,5-TRI-chlorophenyl)-6-substituted-pyrimidines which are pharmacologically active CNS compounds
12/24/1996US5587377 Terazosin crystalline polymorph and pharmaceutical compositions thereof
12/24/1996US5587376 Antiischemic agents, decongestants
12/24/1996US5587375 Azepinone compounds useful in the inhibition of ACE and NEP
12/24/1996CA2176998A1 Novel 17-hydroxyiminoalkyl and 17-hydroxyiminomethylalkenyl cyclopentaneperhydrophenanthrene derivatives active on the cardiovascular system, a process for their preparation and pharmaceutical compositions containing same
12/23/1996CA2179679A1 Substituted benzothiazine derivative
12/20/1996CA2179426A1 Use of ligands specific to rxr receptors
12/19/1996WO1996040921A1 Cdr-grafted anti-tissue factor antibodies and methods of use thereof
12/19/1996WO1996040747A1 Urokinase receptor ligands
12/19/1996WO1996040744A1 KETOHETEROCYCLIC INHIBITORS OF FACTOR Xa
12/19/1996WO1996040686A1 Heterocyclic substituted cyclopentane compounds
12/19/1996WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
12/19/1996WO1996040665A1 N-substituted piperazine nonoates
12/19/1996WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996WO1996040656A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996WO1996040655A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides
12/19/1996WO1996040654A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996WO1996040653A1 Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-3-yl)-acetamides
12/19/1996WO1996040651A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996WO1996040650A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996WO1996040649A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040646A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
12/19/1996WO1996040645A1 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/19/1996WO1996040644A1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
12/19/1996WO1996040640A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
12/19/1996WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists
12/19/1996WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents
12/19/1996WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996WO1996040258A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040257A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040250A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996WO1996040181A1 Processed ginseng having enhanced pharmacological effect
12/19/1996WO1996040146A1 Novel 5-cyclopropyl-1,4 benzodiazepine-2-ones
12/19/1996WO1996040143A1 Imidazole compounds
12/19/1996WO1996040134A1 Calcium channel antagonists
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040118A1 Thrombin inhibitors
12/19/1996WO1996040116A1 Indolinone compounds for the treatment of disease
12/19/1996WO1996040112A1 Use of brefeldin a and derivatives thereof in the treatment of hyperplasia and related disorders
12/19/1996WO1996040098A2 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
12/19/1996WO1996040094A1 Use of selegiline to treat hearing loss in mammals
12/19/1996WO1996040081A2 Oral delivery of gene constructs
12/19/1996WO1996039978A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/19/1996WO1996039833A1 Modulation of calcium channels
12/19/1996WO1996029973A3 Compositions and methods for inhibiting thrombogenesis
12/19/1996CA2224222A1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2224180A1 Ketoheterocyclic inhibitors of factor xa
12/19/1996CA2224079A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2223962A1 2-substituted benzimidazole derivatives
12/19/1996CA2223939A1 2-substituted benzimidazole derivatives
12/19/1996CA2223885A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996CA2223711A1 Calcium channel antagonists
12/19/1996CA2223533A1 Imidazole compounds
12/19/1996CA2223500A1 Thrombin inhibitors
12/19/1996CA2223426A1 N-substituted piperazine nonoates
12/19/1996CA2223268A1 .alpha.-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
12/19/1996CA2222739A1 Modulation of calcium channels
12/19/1996CA2222492A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996CA2222491A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996CA2222472A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996CA2222420A1 Novel 5-cyclopropyl-1,4 benzodiazepine-2-ones
12/19/1996CA2222330A1 Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo¬b|¬1,4|diazepin-3-yl)-acetamides
12/19/1996CA2222316A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
12/19/1996CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996CA2221323A1 Oral delivery of gene constructs
12/19/1996CA2220958A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996CA2220076A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996CA2220006A1 Heterocyclic substituted cyclopentane compounds
12/19/1996CA2219755A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996CA2219417A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
12/19/1996CA2196873A1 Therapeutic use of acetazolamide for the treatment of brain edema
12/19/1996CA2196334A1 Urokinase receptor ligands
12/18/1996EP0748807A1 Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use
12/18/1996EP0748800A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists
12/18/1996EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them
12/18/1996EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof
12/18/1996EP0748376A1 Rna editing enzyme and methods of use thereof
12/18/1996EP0748317A1 Novel thiazolidin-4-one derivatives
12/18/1996EP0748315A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at 1? and at 2?, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same
12/18/1996EP0748314A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same
12/18/1996EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
12/18/1996EP0690855B1 Benzopyranes as potassium channel openers
12/18/1996EP0655059B1 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
12/18/1996EP0635011B1 Hydrazide derivatives of 3,4-dihydro-2h-1-benzopyrans
12/18/1996EP0526598B1 New pharmacologically active catechol derivatives
12/18/1996CN1138333A New pyridazino |4', g':3.4¨ Pyrrolo-|2,1-a¨ isoquinolines and their use for preparing pharmaceutical compositions
12/18/1996CN1138332A Pyridazino quinoline compounds
12/18/1996CN1138328A Heterocyclic compound
12/18/1996CN1138325A Anellated dihydropyridines and their use in the production of pharmaceutical preparations
12/18/1996CN1138324A Anellated dihydropyridines and their use in the production of pharmaceutical preparations
12/18/1996CN1138037A Adhesion receptor antagonists
12/18/1996CN1138029A Fluorophenyl sbstd. alkenylc arboxylic acid-guanidine its preparation method, applied as medicine and diagnosis agent and medicine containing the compound
12/18/1996CN1033585C Preparation of 1,2,4-triazolo(1,5-a) pyrimidine derivatives
12/18/1996CN1033583C Process for preparing 6-(substituted aminopropionyl) derivatives of forskolin
12/17/1996US5585404 3,5,3'-triiodothyronine receptor ligands
12/17/1996US5585394 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives
1 ... 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 ... 1595